Stem cell gene transfer treats IL-1 immune diseases

Italian researchers have successfully ameliorated several IL-1-based autoimmune disorders by gene therapy into transplantable hematopoietic stem cells of mice.

Read more

Glioma drug combo turns tumours hot

An anti-TNF-antibody-cytokine fusion combo with chemotherapy turns inoperable brain tumours hot in mice. A Phase I trial sponsored by Philogen SpA is underway.

Read more

AI predicts an enzyme’s substrate

A new machine learning model can predict enzyme-substrate pairs, with an accuracy of over 90% and is ready to be used in pharmaceutical and industrial biotechnology.

Read more

LanzaTech and Plastipak produce greener PET

Carbon-capture specialist LanzaTech Global and Plastipak Packaging Inc have produced the  world’s first PET resin made from captured carbon emissions.

Read more

Roche’s meets endpoints in relapsing multiple sclerosis

Roche’s bruton’s tyrosine kinas blocker fenebrutinib has met all endpoints in proof-of-concept study with patients suffering from relapsing-remitting multiple sclerosis.

Read more

Dualyx NV raises €40m in Series A financing

Belgian T reg specialist Dualyx NV had raised €40m to progress its three preclinical Treg candidates for autoimmune diseases into the clinic.

Read more

Mainz Biomed Partners with Microba Life Sciences

Molecular diagnostics specialist Mainz Biomed NV has inked a research collaboration with precision microbiome firm Microba Life Sciences Inc.

Read more

DiogenX SA raises €27.5M in Series A financing

French pancreatic beta-cell modulator specialist DiogenX SA has raised €27.5m in a Series A financing led by Boehringer Ingelheim Venture Fund and Roche Venture Fund.

Read more